Bright Minds Biosciences Stock Buy Hold or Sell Recommendation
| DRUG Stock | USD 44.00 4.82 12.30% |
Given the investment horizon of 90 days and your below-average risk tolerance, our recommendation regarding Bright Minds Biosciences is 'Strong Sell'. Macroaxis provides Bright Minds buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding DRUG positions.
Check out Bright Minds Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Bright and provide practical buy, sell, or hold advice based on investors' constraints. Bright Minds Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
Bright |
Execute Bright Minds Buy or Sell Advice
The Bright recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Bright Minds Biosciences. Macroaxis does not own or have any residual interests in Bright Minds Biosciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Bright Minds' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Good | Details | |
Volatility | Out of control | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | About Average | Details | |
Economic Sensitivity | Moves completely opposite to the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Sell | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Bright Minds Trading Alerts and Improvement Suggestions
| Bright Minds is way too risky over 90 days horizon | |
| Bright Minds appears to be risky and price may revert if volatility continues | |
| Bright Minds has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (7.37 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Bright Minds Biosciences currently holds about 8.64 M in cash with (7.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.71. | |
| Bright Minds has a frail financial position based on the latest SEC disclosures | |
| Roughly 27.0% of the company shares are held by company insiders | |
| Latest headline from investing.com: Baird assigns Outperform to Bright Minds stock, sees positive readthrough from recent MA |
Bright Minds Returns Distribution Density
The distribution of Bright Minds' historical returns is an attempt to chart the uncertainty of Bright Minds' future price movements. The chart of the probability distribution of Bright Minds daily returns describes the distribution of returns around its average expected value. We use Bright Minds Biosciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Bright Minds returns is essential to provide solid investment advice for Bright Minds.
| Mean Return | 24.90 | Value At Risk | -11.87 | Potential Upside | 12.30 | Standard Deviation | 4,400 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Bright Minds historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Bright Stock Institutional Investors
| Shares | Advisorshares Investments, Llc | 2024-09-30 | 182.4 K | Jane Street Group Llc | 2024-06-30 | 10.9 K | Royal Bank Of Canada | 2024-06-30 | 510 | Aspire Private Capital, Llc | 2024-09-30 | 100.0 | Blackrock Inc | 2024-06-30 | 1.0 |
Bright Minds Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 719.9K | 19.0M | (8.1M) | (4.9M) | (4.4M) | (4.2M) | |
| Free Cash Flow | (288.4K) | (7.3M) | (13.6M) | (7.0M) | (6.3M) | (6.6M) | |
| Other Non Cash Items | 161.3K | 144.8K | (229.6K) | 65.1K | 58.6K | 40.3K | |
| Net Income | (480.4K) | (8.7M) | (15.0M) | (7.4M) | (6.6M) | (7.0M) | |
| End Period Cash Flow | 799.9K | 19.8M | 11.6M | 6.7M | 7.8M | 8.6M |
Bright Minds Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Bright Minds or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Bright Minds' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Bright stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 29.00 | |
β | Beta against Dow Jones | -32.22 | |
σ | Overall volatility | 127.69 | |
Ir | Information ratio | 0.14 |
Bright Minds Volatility Alert
Bright Minds Biosciences is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Bright Minds' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Bright Minds' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Bright Minds Fundamentals Vs Peers
Comparing Bright Minds' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Bright Minds' direct or indirect competition across all of the common fundamentals between Bright Minds and the related equities. This way, we can detect undervalued stocks with similar characteristics as Bright Minds or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Bright Minds' fundamental indicators could also be used in its relative valuation, which is a method of valuing Bright Minds by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Bright Minds to competition |
| Fundamentals | Bright Minds | Peer Average |
| Return On Equity | -0.52 | -0.31 |
| Return On Asset | -0.29 | -0.14 |
| Current Valuation | 300.32 M | 16.62 B |
| Shares Outstanding | 6.08 M | 571.82 M |
| Shares Owned By Insiders | 27.28 % | 10.09 % |
| Shares Owned By Institutions | 44.27 % | 39.21 % |
| Number Of Shares Shorted | 264.76 K | 4.71 M |
| Price To Book | 70.58 X | 9.51 X |
| EBITDA | (7.28 M) | 3.9 B |
| Net Income | (7.37 M) | 570.98 M |
| Cash And Equivalents | 8.64 M | 2.7 B |
| Cash Per Share | 0.71 X | 5.01 X |
| Total Debt | 73.55 K | 5.32 B |
| Current Ratio | 22.88 X | 2.16 X |
| Book Value Per Share | 1.37 X | 1.93 K |
| Cash Flow From Operations | (7.02 M) | 971.22 M |
| Short Ratio | 0.04 X | 4.00 X |
| Earnings Per Share | (0.63) X | 3.12 X |
| Target Price | 4.87 | |
| Beta | 1.13 | -0.15 |
| Market Capitalization | 268.26 M | 19.03 B |
| Total Asset | 6.88 M | 29.47 B |
| Retained Earnings | (31.55 M) | 9.33 B |
| Working Capital | 6.53 M | 1.48 B |
| Net Asset | 6.88 M |
Note: Acquisition by Cormorant Asset Management, Lp of 184331 shares of Bright Minds at 21.7 subject to Rule 16b-3 [view details]
Bright Minds Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Bright . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Bright Minds Buy or Sell Advice
When is the right time to buy or sell Bright Minds Biosciences? Buying financial instruments such as Bright Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Bright Minds in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Treasury ETFs Thematic Idea Now
Treasury ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Treasury ETFs theme has 114 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Treasury ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Bright Minds Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bright Minds. If investors know Bright will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bright Minds listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.63) | Return On Assets (0.29) | Return On Equity (0.52) |
The market value of Bright Minds Biosciences is measured differently than its book value, which is the value of Bright that is recorded on the company's balance sheet. Investors also form their own opinion of Bright Minds' value that differs from its market value or its book value, called intrinsic value, which is Bright Minds' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bright Minds' market value can be influenced by many factors that don't directly affect Bright Minds' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bright Minds' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bright Minds is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bright Minds' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.